These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 313269)

  • 1. Inhibition of modulation of thymus-leukemia antigens by concanavalin A.
    Wilson CB; Little JR
    Cell Immunol; 1979 May; 44(2):416-23. PubMed ID: 313269
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of T cell-mediated cytolysis: an investigation of cells and stages affected by cytolysis-inhibiting monoclonal antibodies.
    Hayot B; Pierres M; Golstein P
    Adv Exp Med Biol; 1982; 146():469-85. PubMed ID: 6980571
    [No Abstract]   [Full Text] [Related]  

  • 3. The redistribution of fluoresceinated concanavalin A in Chinese hamster ovary cells and in their colcemid-resistant mutants.
    Aubin JE; Tolson N; Ling V
    Exp Cell Res; 1980 Mar; 126(1):75-85. PubMed ID: 7358097
    [No Abstract]   [Full Text] [Related]  

  • 4. Microtubule assembly and conanavalin A capping in lymphocytes: reappraisal using normal and abnormal human peripheral blood cells.
    Oliver JM; Gelfand EW; Pearson CB; Pfeiffer JR; Dosch HM
    Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3499-503. PubMed ID: 6968071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
    Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
    Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential effects of distinct cytolysis-inhibiting monoclonal antibodies on growth and on cytolytic activity of T cell clones.
    Schmitt-Verhulst AM; Golstein P; Buferne M; Pierres M
    Adv Exp Med Biol; 1982; 146():521-32. PubMed ID: 6980573
    [No Abstract]   [Full Text] [Related]  

  • 7. [Lateral diffusion of the concanavalin A and immunoglobulin receptors on the surface of lymphocyte plasma membranes on exposure to antigen].
    Sitovskiĭ MV; Vardanian IK; Golubeva NN; Kozlov IuP
    Biofizika; 1979; 24(5):938-9. PubMed ID: 314821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 9. Cell membrane receptor classes delimited through cap formation either with diamide or with membrane mobility agent, A2C.
    Kosower NS; Faltin Z; Kosower EM
    J Immunol Methods; 1981; 41(2):215-23. PubMed ID: 7264314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural killers and macrophages: their activity in leukemias].
    Fi FT
    Eksp Med Morfol; 1985; 24(2):63-70. PubMed ID: 3933945
    [No Abstract]   [Full Text] [Related]  

  • 11. Production of macrophage activating factor by cytolytic and noncytolytic T lymphocyte clones.
    Kelso A; Glasebrook AL; Brunner KT; Kanagawa O; Engers HD; MacDonald HR; Cerottini JC
    Adv Exp Med Biol; 1982; 155():493-8. PubMed ID: 6760696
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of interferon on cell membrane of mouse lymphocytes. Inhibition of ligand-induced redistribution of surface receptors.
    Matsuyama M
    Exp Cell Res; 1979 Dec; 124(2):253-9. PubMed ID: 510417
    [No Abstract]   [Full Text] [Related]  

  • 13. Mitogenic stimulation and the redistribution of concanavalin A receptors on lymphocytes.
    Pozzan T; Corps AN; Hesketh TR; Metcalfe JC
    Exp Cell Res; 1981 Aug; 134(2):399-408. PubMed ID: 7274339
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane fluidity, capping of cell-surface antigens and immune response in mouse leukaemia cells.
    Hilgers J; van der Sluis PJ; van Blitterswijk WJ; Emmelot P
    Br J Cancer; 1978 Mar; 37(3):329-36. PubMed ID: 346039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes occurring on the surface of mouse T cells during concanavalin A-induced lymphoblastic transformation.
    Kierszenbaum F; Budzko DB
    Immunology; 1979 Dec; 38(4):827-34. PubMed ID: 391704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and structural requirements for concanavalin A capping in phagocytic cells.
    Williams DA; Lessard J; Boxer LA; Rein D; Baehner RL
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):34-7. PubMed ID: 504238
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune response of mice to concanavalin A-coated EL 4 leukemia.
    Martin WJ; Wunderlich JR
    Natl Cancer Inst Monogr; 1972 Dec; 35():295-9. PubMed ID: 4679048
    [No Abstract]   [Full Text] [Related]  

  • 18. The participation of adenylate cyclase in lymphocyte capping.
    Bourguignon LY; Hsing YC
    Biochim Biophys Acta; 1983 Feb; 728(2):186-90. PubMed ID: 6131691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 20. Feline lymphocytes: observations on surface membrane concanavalin A receptor mobility.
    Nichols WS; Dunlap JE; Hebebrand LC; Mathes LE; Olsen RG
    Am J Vet Res; 1979 Jul; 40(7):959-61. PubMed ID: 507498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.